Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.19.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Accounts receivable, net of allowance [1] $ 91,755 $ 85,985
Accounts receivable, allowance $ 2,587 $ 2,765
Preferred stock, par value (in usd per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common Class A    
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 31,134,154 30,366,546
Common stock, shares outstanding (in shares) 29,033,114 28,275,506
Treasury stock, shares (in shares) 2,101,040 2,091,040
Common Class B    
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 144,000,000 144,000,000
Common stock, shares issued (in shares) 18,000,000 18,000,000
Common stock, shares outstanding (in shares) 18,000,000 18,000,000
[1] Includes restricted assets of consolidated variable interest entities (“VIEs”) at September 30, 2019 and December 31, 2018 of $136,213 and $126,727, respectively. Includes non-recourse liabilities of consolidated VIEs at September 30, 2019 and December 31, 2018 of $39,548 and $34,684, respectively. See Note 12.